Skip navigation

Chemical Sugar Acids

1–50 of 835 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 1-O-(2-((2',6'-dichlorophenyl)amino)phenylacetyl)glucopyranuronic acid protein modification process 1-O-(2-((2',6'-dichlorophenyl)amino)phenylacetyl)glucopyranuronic acid results in increased protein modification process 1: Homo sapiens Microsomes, Liver   1
2. 3-phosphoglycerate glycolytic process Permethrin | Pyridostigmine Bromide [[Pyridostigmine Bromide co-treated with Permethrin] affects glycolytic process] which results in decreased abundance of 3-phosphoglycerate 1: Mus musculus Brain 1 gene: GAPDH 1
3. 6-O-palmitol-ascorbate-2-O-phosphate response to mechanical stimulus 6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus 1: Mus musculus Cartilage, Articular | Chondrocytes   1
4. 6-O-palmitol-ascorbate-2-O-phosphate positive regulation of superoxide anion generation response to mechanical stimulus [6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus] which results in decreased positive regulation of superoxide anion generation 1: Mus musculus Cartilage, Articular | Chondrocytes   1
5. 6-O-palmitol-ascorbate-2-O-phosphate response to mechanical stimulus positive regulation of superoxide anion generation [6-O-palmitol-ascorbate-2-O-phosphate results in decreased response to mechanical stimulus] which results in decreased positive regulation of superoxide anion generation 1: Mus musculus Cartilage, Articular | Chondrocytes   1
6. 7-ethyl-10-hydroxycamptothecin glucuronide drug metabolic process Paclitaxel [Paclitaxel results in increased drug metabolic process] which results in increased abundance of 7-ethyl-10-hydroxycamptothecin glucuronide 1: Mus musculus Hepatocytes | Cells, Cultured   1
7. 7-ethyl-10-hydroxycamptothecin glucuronide drug metabolic process Paclitaxel | TLR4 TLR4 protein mutant form inhibits the reaction [[Paclitaxel results in increased drug metabolic process] which results in increased abundance of 7-ethyl-10-hydroxycamptothecin glucuronide] 1: Mus musculus Hepatocytes | Cells, Cultured   1
8. N-Acetylneuraminic Acid bone development NANSA N-Acetylneuraminic Acid inhibits the reaction [NANSA gene mutant form results in decreased bone development] 1: Danio rerio Bone and Bones   1
9. N-Acetylneuraminic Acid N-acetylneuraminate metabolic process Quercetin [Quercetin affects N-acetylneuraminate metabolic process] which results in increased abundance of N-Acetylneuraminic Acid 1: Rattus norvegicus Esophagus
2 genes: CMAS | GNE
1
10. N-Acetylneuraminic Acid N-acetylneuraminate metabolic process Omeprazole [Omeprazole affects N-acetylneuraminate metabolic process] which results in increased abundance of N-Acetylneuraminic Acid 1: Rattus norvegicus Esophagus
2 genes: CMAS | GNE
1
11. Sialic Acids histamine secretion mediated by immunoglobulin Spermine Sialic Acids affects the reaction [Spermine results in increased histamine secretion mediated by immunoglobulin] 1: Rattus norvegicus Mast Cells   1
12. Sialic Acids histamine secretion mediated by immunoglobulin arcaine Sialic Acids affects the reaction [arcaine results in increased histamine secretion mediated by immunoglobulin] 1: Rattus norvegicus Mast Cells   1
13. Sialic Acids renal system process involved in regulation of systemic arterial blood pressure Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides affects renal system process involved in regulation of systemic arterial blood pressure] 1: Rattus norvegicus Blood   1
14. Sialic Acids renal system process involved in regulation of blood volume Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides affects renal system process involved in regulation of blood volume] 1: Rattus norvegicus Kidney | Blood   1
15. Sialic Acids positive regulation of necrotic cell death Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased positive regulation of necrotic cell death] 1: Rattus norvegicus Kidney   1
16. Sialic Acids positive regulation of inflammatory response Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased positive regulation of inflammatory response] 1: Rattus norvegicus Kidney 1 gene: TLR4 1
17. Sialic Acids positive regulation of autophagy Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased positive regulation of autophagy] 1: Rattus norvegicus Kidney 1 gene: BECN1 1
18. Sialic Acids autophagic cell death Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased autophagic cell death] 1: Rattus norvegicus Kidney   1
19. Sialic Acids positive regulation of apoptotic process Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased positive regulation of apoptotic process] 1: Rattus norvegicus Kidney
4 genes: BAX | CASP1 | IL1B | TLR4
1
20. Sialic Acids pyroptosis Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased pyroptosis] 1: Rattus norvegicus Kidney 1 gene: CASP1 1
21. Sialic Acids ER overload response Lipopolysaccharides Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased ER overload response] 1: Rattus norvegicus Kidney   1
22. ascorbate-2-phosphate membrane lipid catabolic process ascorbate-2-phosphate results in decreased membrane lipid catabolic process 1: Rattus norvegicus Liver | Hepatocytes | Cell Line, Tumor   1
23. Ascorbic Acid apoptotic process Ascorbic Acid results in decreased apoptotic process 1: Homo sapiens HL-60 Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
24. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds [Ferrous Compounds co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process     1
25. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds | Propofol Propofol inhibits the reaction [[Ascorbic Acid co-treated with Ferrous Compounds] results in increased membrane lipid catabolic process]     1
26. Ascorbic Acid membrane lipid catabolic process Ferrous Compounds | Vitamin E Vitamin E inhibits the reaction [[Ascorbic Acid co-treated with Ferrous Compounds] results in increased membrane lipid catabolic process]     1
27. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 2: Mus musculus | Rattus norvegicus Brain   2
28. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Liver   1
29. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Kidney   1
30. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Lung   1
31. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Heart   1
32. Ascorbic Acid membrane lipid catabolic process ferrous sulfate [ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process 1: Rattus norvegicus Aorta   1
33. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Brain   1
34. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Liver   1
35. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Kidney   1
36. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Lung   1
37. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Heart   1
38. Ascorbic Acid membrane lipid catabolic process ferrous sulfate | Propofol Propofol inhibits the reaction [[ferrous sulfate co-treated with Ascorbic Acid] results in increased membrane lipid catabolic process] 1: Rattus norvegicus Aorta   1
39. Ascorbic Acid apoptotic process AGT Ascorbic Acid inhibits the reaction [AGT protein modified form results in increased apoptotic process] 1: Mus musculus Cell Line, Transformed | Mesangial Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
40. Ascorbic Acid apoptotic process Ascorbic Acid results in increased apoptotic process 1: Homo sapiens Colon | Tumor Cells, Cultured
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
41. Ascorbic Acid apoptotic process Adenosine Triphosphate | Vitamin E [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Adenosine Triphosphate results in increased apoptotic process] 1: Rattus norvegicus Adrenal Glands | PC12 Cells
78 genes: AKT1 | APP | ATM | BAD | BAK1 | BAX | BBC3 | BCL2 | BCL2L1 | BCL2L14 | BCL2L2 | BIRC3 | BIRC5 | BUB1 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CD14 | CDK1 | CDK11A | CDKN2A | CHEK2 | CITED1 | CYCS | DAB2 | DDIT3 | DNASE1 | DPF1 | EGLN3 | ERCC2 | G0S2 | GABARAP | GADD45B | GAPDH | GPX1 | GZMB | HMOX1 | IAPP | IER3 | IFNG | IL1B | KIF1B | LCK | LGALS1 | MALT1 | MAP2K6 | MAP3K5 | MAPK1 | MAPK14 | MAPK3 | MAPT | MT3 | NFKB1 | NFKBIA | NR3C1 | PARP1 | PHLDA1 | PHLDA2 | PMAIP1 | PRDX3 | PRF1 | PRKCB | SNCA | STK17B | TF | TLR2 | TNF | TNFRSF11B | TNFSF10 | TP53 | TRIB3 | TRP53 | TSPO | VDAC1
1
42. Ascorbic Acid cell death 2,3,2-tetramine [2,3,2-tetramine co-treated with Ascorbic Acid] results in increased cell death 1: Homo sapiens Blood Cells | HL-60 Cells
8 genes: CDKN1B | CTSD | EMP1 | EMP3 | HMOX1 | OLR1 | PMP22 | TGFB2
1
43. Ascorbic Acid membrane lipid catabolic process potassium bromate Ascorbic Acid inhibits the reaction [potassium bromate results in increased membrane lipid catabolic process] 1: Rattus norvegicus Kidney   1
44. Ascorbic Acid regulation of organ growth potassium bromate Ascorbic Acid inhibits the reaction [potassium bromate results in increased regulation of organ growth] 1: Rattus norvegicus Kidney 1 gene: SOD1 1
45. Ascorbic Acid membrane lipid catabolic process ferric ammonium citrate Ascorbic Acid affects the reaction [ferric ammonium citrate results in increased membrane lipid catabolic process] 1: Rattus norvegicus Myocardium | Cells, Cultured   1
46. Ascorbic Acid DNA catabolic process Bleomycin Ascorbic Acid promotes the reaction [Bleomycin results in increased DNA catabolic process]   1 gene: DNASE1 1
47. Ascorbic Acid membrane lipid catabolic process CAT CAT inhibits the reaction [Ascorbic Acid results in increased membrane lipid catabolic process] 1: Rattus norvegicus Epidermis | Microsomes   1
48. Ascorbic Acid membrane lipid catabolic process adenosine diphosphate-ferric chelate [Ascorbic Acid co-treated with adenosine diphosphate-ferric chelate] results in increased membrane lipid catabolic process 1: Rattus norvegicus Epidermis | Microsomes   1
49. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in increased membrane lipid catabolic process 1: Rattus norvegicus Epidermis | Microsomes   1
50. Ascorbic Acid membrane lipid catabolic process Ascorbic Acid results in decreased membrane lipid catabolic process 1: Rattus norvegicus Microsomes, Liver   1
1–50 of 835 results.